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Mitochondrial dysfunction has been demonstrated to result in premature aging due to its effects on stem cells. Nevertheless, a full
understanding of the role of mitochondrial bioenergetics through differentiation is still lacking. Here we show the bioenergetics
profile of human stem cells of embryonic origin differentiating along the hepatic lineage. Our study reveals especially the
transition between hepatic specification and hepatic maturation as dependent on mitochondrial respiration and demonstrates
that even though differentiating cells are primarily dependent on glycolysis until induction of hepatocyte maturation, oxidative
phosphorylation is essential at all stages of differentiation.
1. Introduction
Mutations of the mitochondrial polymerase gamma cause a
mitochondrial DNA (mtDNA) mutator phenotype which in
mice has been correlated to premature aging and decreased
lifespan [1, 2]. The progeroid phenotype is demonstrated
to be primarily elicited through the effect of mitochondrial
dysfunction on stem cells, rather than on postmitotic cells
[3]. The purpose of this work is to provide a detailed under-
standing of the need of mitochondrial function throughout
differentiation of stem cells in order to better understand the
relationship between dysfunctional mitochondria, stem cell
differentiation, and premature aging.
The human mtDNA exclusively encodes 24 peptides
needed for mitochondrial protein synthesis and 13 essen-
tial subunits of the mitochondrial electron transport chain
(ETC) and ATP synthase. Together they produce ATP by
oxidative phosphorylation in an aerobic process. ATP can
also be produced by glycolysis in an anaerobic process. The
preference of cells for oxidative phosphorylation or glycolysis
is determined by cell type, state of the cell, and the availability
of oxygen. Oxidative phosphorylation is more efficient in
producing ATP when compared to glycolysis. Conversely,
glycolysis has the ability to produce ATP at a higher rate
thanmitochondrial respiration and can provide more carbon
intermediates necessary for biosynthesis (reviewed in [4]).
Embryonic stem cells (ESC) have a preference for gly-
colysis [5, 6]. During differentiation, however, changes of
mitochondrial morphology indicate a fluctuating prefer-
ence towards oxidative phosphorylation. During this process
mitochondrial networks expand to adopt the more sporadic
cytoplasmic configuration seen in typical somatic cells within
differentiated tissue [5, 7]. Furthermore, there is an increase
in copy-number ofmtDNAencoding subunits of the ETC [8].
As a result, stem cells increase their oxygen consumption 10-
fold in the course of differentiation [7].
The flux between glycolysis and oxidative phosphory-
lation not only is a marker of differentiation status but is
also essential for stem cell fate. Suppression of oxidative
phosphorylation retards differentiation of stem cells [9, 10],
while inhibition of glycolysis halts proliferation and promotes
cell death [6]. Furthermore, during dedifferentiation, or
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upon induction of pluripotency, mitochondrial morphology
reverts to that of stem cells displaying immature spherical
and cristae-poor structures [11, 12], and, in itself, promotion
of glycolysis at the expense of oxidative phosphorylation
promotes dedifferentiation [12].
While mitochondrial dysfunction in stem cells has been
demonstrated to result in a progeroid phenotype [3], the
underlying mechanism is largely unknown. In this study,
the cellular utilization of oxidative phosphorylation and
glycolysis is determined at specific time points in the course
of a 20-day differentiation protocol of stem cells of human
embryonic origin along the hepatic lineage. This study
highlights especially the transition from hepatic specifica-
tion to hepatic maturation as dependent on mitochondrial
respiration. Together, this will help elucidating the role of
mitochondria in the regulation of stem cells and progeria.
2. Materials and Methods
2.1. Materials. The human embryonic stem cell line
BG01V/hOG (hESC) can be purchased from Thermo Fisher
Scientific (http://www.thermofisher.com). This cell line is
a variant derived from the BG01V hESC line genetically
modified to express Emerald Green Fluorescent Protein
(EmGFP) under the Oct4-promotor wherefore visual
inspection of the GFP expression can be used to verify
pluripotency [13].
All media and supplements were obtained from Thermo
Fisher Scientific or Sigma-Aldrich (http://www.sigmaaldrich
.com) unless otherwise stated. Antibodies were acquired
from R&D Systems (http://www.rndsystems.com), Dako
(http://www.dako.com), Santa Cruz Biotechnology (http://
www.scbt.com), Abcam (http://www.abcam.com), andTher-
mo Fisher Scientific.
2.2. Cell Culture. The BG01V/hOG cell line was cultured on
mitotically inactivated mouse embryonic fibroblasts (MEF)
in hESC media containing DMEM/F-12 media (1 : 1) supple-
mented with GlutaMAX, 20% Knockout Serum Replace-
ment, nonessential amino acids, 2-mercaptoethanol at 0.1M,
basic fibroblast growth factor at 4 ng/mL (R&D Systems), and
penicillin/streptomycin at 100 units/mL. Cells were cultured
at 37∘C under atmospheric O
2
and 5% CO
2
.
2.3. Cell Differentiation. Prior to differentiation the BG01V/
hOG cells were passaged to a feeder-free system com-
posed of mTeSR1 media (STEMCELL Technologies,
http://www.stemcell.com) and Matrigel (BD Biosciences,
http://www.bdbiosciences.com) coated plates. Cells were
passaged at least twice in this system to remove mitotically
inactivated MEF from the BG01V/hOG cell culture. For
differentiation along the hepatic lineage, BG01V/hOG
cells were passaged to plates coated with 0.1% porcine
gel. The cells were then subjected to 20-day media
regime consisting of daily media changes (Figure 1(a)) as
described in Touboul et al. [14]. For indirect immunofluores-
cence analyses BG01V/hOG cells were seeded in 48-well
plates (Corning Life Sciences, http://www.corning.com)
at 21,000 cells/cm2. For determination of glycolysis and
mitochondrial respiration BG01V/hOG cells were seeded in
Seahorse XF24 cell culture microplates (Seahorse Bioscience,
http://www.agilent.com) at various densities to adjust for
cellular growth through differentiation. Cell plates harvested
at different time points were at day 0 seeded in following
number: Day 2 (100,000 cells/cm2), Day 5 (80,000 cells/cm2),
Day 10 (60,000 cells/cm2), Day 15 (40,000 cells/cm2), and
Day 20 (20,000 cells/cm2). Three wells were trypsinized
from Seahorse microplates prior to analyses and cells
were counted to ensure that the number of cells per
Seahorse well at harvest was approximately 100,000 cells/cm2
(Figure 2(c)). In brief, cells for differentiation were cultured
in a chemically defined media (CDM) supplemented with
small molecules and growth factors. The composition of
CDM was as follows: Iscove’s Modified Dulbecco’s Medium
and Ham’s F12 Medium both with GlutaMAX at a 1 : 1 ratio
supplemented with chemically defined lipid concentrate at
1x, penicillin/streptomycin at 100 units/mL, bovine serum
albumin fractionV at 5mg/mL,monothioglycerol at 450 𝜇M,
holotransferrin at 15 𝜇g/mL (R&D Systems), and insulin
at 7𝜇g/mL. Cells were kept in an incubator at 37∘C under
atmospheric O
2
and 5% CO
2
. At the time points indicated in
Figure 1(a), the composition of the medium was altered by
addition of the specified small molecules and growth factors
to support a specific period in the differentiation process
along the hepatic lineage. Plates were harvested for analyses
at the following time points: Day 2: Stem Cell, after 2 days’
culturing in Stem Cell media; Day 5: Endo Diff, after 3 days’
exposure in definitive endoderm induction media; Day 10:
Hep Spec, after 5 days’ induction in hepatic specification
media; Day 15: Early Hep Mat, after 5 days’ induction in
hepatocyte maturation media; and finally Day 20: Late Hep
Mat, after 10 days’ induction in hepatocytematurationmedia.
2.4. Indirect Immunofluorescence Analysis. Differentiating
BG01V/hOG cells were fixed in paraformaldehyde (4%) for
15min at room temperature (RT) on Days 2, 5, 10, 15, and
20, respectively. Plates were stored at 4∘C until all time
points were collected (maximum 20 days) and analysed
collectively under identical conditions. Samples were perme-
abilized with Triton X-100 (0.5%) for 20min at RT, before
incubation with blocking solution containing 10% donkey
or goat serum for 1 hour at RT. Subsequently, the samples
were incubated overnight at 4∘C with primary antibodies
followed by 30min incubation at RT with secondary anti-
bodies (Table 1) and finally mounted with ProLong Gold
containing DAPI. The samples were imaged using a Zeiss
LSM 780 laser scanning confocal microscope (the Core
Facility for Integrated Microscopy, Faculty of Health and
Medical Sciences, University of Copenhagen, Denmark). To
establish a comparative series of images, the confocal laser
used was optimized at the stage showing the peak intensity
for each antibody series and microscope parameters were
copied and used for that specific antibody through all plates.
Stains without primary or secondary antibodies provided
internal controls to establish target specificity of antibodies.
For quantification of the cellularmitochondrial network areas
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Figure 1: Continued.
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Figure 1: (a) Schematic presentation of the differentiation protocol [14] used to measure the bioenergetics in the course of BG01V/hOG
(hESC) line differentiation along the hepatic lineage. (b) Expression of the pluripotency marker OCT4 visualized by detection of EmGFP
(in green) and immunofluorescence detection of the definitive endoderm marker SOX17 and the hepatic differentiation markers HNF4𝛼,
AFP, CK19, and albumin, all shown in red, in the course of BG01V/hOG (hESC) line differentiation along the hepatic lineage. Nuclei are
highlighted with DAPI staining shown in blue. Scale bars represent 50 𝜇m (50 microns). (c) Expression profile of miRNA-122 detected by
real-time RT-PCR in the course of BG01V/hOG (hESC) line differentiation along the hepatic lineage.
Table 1: Antibodies and their origin and dilutions used in the indirect immunofluorescence analyses.
Antibody Dilution Company Catalog number Secondary antibody (1 : 400)
SOX17 10 𝜇g/ml R&D Systems AF1924 Alexa Fluor 594 donkey anti-goat, A11058
HNF-4𝛼 1 : 50 Santa Cruz Biotechnology SC-6556 Alexa Fluor 594 donkey anti-goat, A11058
AFP 1 : 7000 Dako A0008 Alexa Fluor 594 donkey anti-rabbit, A21207
CK19 1 : 50 Dako M0888 Alexa Fluor 594 goat anti-mouse, A21125
EpCAM 1 : 200 Dako M0804 Alexa Fluor 594 goat anti-mouse, A21125
ALB 1 : 400 Dako A0001 Alexa Fluor 594 donkey anti-rabbit, A21207
COX IV 1 : 100 Abcam Ab97770 Alexa Fluor 594 donkey anti-rabbit, A21207
during the course of hepatic lineage differentiation ImageJ
(http://www.imagej.net) was used. The number of cells per
image was assessed by nuclear DAPI staining and area of
mitochondrial networks was assessed using immunofluores-
cence staining of the mitochondrial marker COX4. Average
area of mitochondrial network per cell was calculated by
dividing total area of mitochondrial network in the image by
the number of nuclei in the image.
2.5. Real-Time RT-PCR Analyses. Real-time RT-PCR quan-
tification ofmiRNAexpressionwas carried out usingTaqMan
MicroRNA Assay Kits for miRNA-122 according to the man-
ufacturer’s protocol (Applied Biosystems, Life Technologies
Corporation). In brief, cells were seeded at 21,000 cells/cm2
and induced to differentiate. Total RNA was extracted from
cell cultures using TRIzol Reagent (Invitrogen, Carlsbad, CA,
USA), and 10 ng of total RNA was reverse transcribed. Real-
time PCR analysis was performed at 95∘C for 10min, followed
by 40 cycles of 95∘C for 15 sec and 60∘C for 1min. All reactions
were done in triplicate. CT was determined using threshold
settings adjusted for miRNA-122 based on standard curves of
10-fold dilutions.The threshold value was placed in the linear
phase of exponential amplification and set at a point that
maximised the precision of replicates. Results were expressed
as fold change in miRNA-122 expression as compared to the
Day 2 time point calculated as 2−ΔCt.
2.6. Determination of Glycolysis and Mitochondrial Respira-
tion. Mitochondrial bioenergetics of BG01V/hOG cells in
the course of differentiation along the hepatic lineage were
measured at the five different time points using an XF24
Extracellular Flux Analyzer (Seahorse Bioscience,). For each
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Figure 2: (a) Immunofluorescence detection of COX4 visualized in red in the course of BG01V/hOG cell differentiation along the hepatic
lineage. Nuclei are highlighted with DAPI staining shown in blue. Scale bars represent 50 𝜇m (50 microns). (b) Quantification of cellular
areas covered by mitochondrial networks in the course of BG01V/hOG cell differentiation along the hepatic lineage. (c) To ensure equal cell
numbers of approximately 100,000 cells/cm2 at harvest for bioenergetics analyses cells were seeded at different densities and cell numbers
counted at harvest as shown in (c).
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time point, measurements were made from 8 independent
inductions. At harvest, the Seahorse plates were washed and
Seahorse assay media (Seahorse Bioscience) were added,
supplemented with pyruvate at 1mM and glutamine at 2mM,
and adjusted to pH 7.6. Plates were incubated in a CO
2
-free
incubator at 37∘C for 1 hour to allow temperature and pH
equilibration, after which oxygen consumption rate (OCR)
as well as extracellular acidification rate (ECAR) of each
well was measured in the XF24 Extracellular Flux Analyzer
over a period of 144 minutes. For determination of oxida-
tive phosphorylation properties, the ATP synthase inhibitor
oligomycin at 0.75𝜇M, the uncoupler carbonyl cyanide-4-
(trifluoromethoxy)phenylhydrazone (FCCP) at 1 𝜇M, and
complex III inhibitor antimycin A at 2𝜇M were added to
wells after 27, 63, and 108 minutes, respectively. This allowed
the determination of basal ATP turnover, maximal respi-
ration, and reserve respiratory capacity. For determination
of glycolytic properties, D-glucose at 10mM, oligomycin
at 0.75 𝜇M, and the glycolytic inhibitor 2-deoxy-D-glucose
(2DG) at 150mM were added at the same time points. For
determination of oxidative phosphorylation and glycolysis,
OCR and ECAR measurements used for calculation were
taken immediately before addition of next compound. This
allowed the determination of basal rate of glycolysis and
glycolytic reserve capacity.
2.7. Statistics. Single classification analysis of variance
(ANOVA) was used to test differences between bioenergetic
properties. Assumptions of normality were checked by visual
inspection prior to ANOVA. When the ANOVA indicated
significant differences, Tukey’s honestly significant method
was used to test for differences between bioenergetics
properties.
3. Results
3.1. Human Embryonic Stem Cell Differentiation along the
Hepatic Lineage. The 20-day differentiation protocol from
Touboul el al. [14] was used to differentiate BG01V/hOG
human embryonic stem cells along the hepatic lineage
into hepatocyte-like cells. Cell differentiation was followed
by immunofluorescent detection of verified differentiation
markers in the hepatic lineage (Figure 1(b)).
As visualized by EmGFP expression and consistent with
the results presented by Touboul et al., transcription of the
pluripotency marker OCT4 was active at Day 2 in stem cells.
At Day 5, upon 3 days’ induction in definitive endoderm
media, some cells were still actively transcribing OCT4.
However, at the same time point a nuclear expression of the
definitive endoderm marker protein SOX17, a transcription
factor important in the developmental process between endo-
derm formation and early gut formation, was detected. The
SOX17 protein expression was sustained at Day 10 following
culture in the hepatic specification media for 5 days but
suppressed at the later time points after culture in hepatocyte
maturation media. Immunofluorescence staining of hepato-
cyte nuclear factor 4𝛼 (HNF4𝛼) protein, a nuclear factor
required for hepatic lineage differentiation and development
of the liver, revealed low cytoplasmic expression atDays 2 and
5 and peak expression and translocation to the nucleus from
Day 10 to the end of the differentiation regimen. A similar
transcription profile was observed in a real-time RT-PCR
analysis of miRNA-122 (Figure 1(c)). The expression of this
highly liver specific microRNA is developmentally regulated
and increases in the liver over the course of development
constituting approximately 70% of the miRNA pool in the
adult liver [15]. Interestingly, HNF4𝛼 has been shown to reg-
ulate the expression of miRNA-122 [16]. Therefore, the con-
comitant expression profiles of these two parameters strongly
indicate a specification to the hepatic lineage between Day 5
and Day 10 in the presented differentiation protocol.This was
further supported by the expression profiles of 𝛼-fetoprotein
(AFP) andCytokeratin 19 (CK19) (Figure 1(b)).𝛼-Fetoprotein
is a major plasma protein expressed in emerging hepatocytes
during embryonic and fetal liver development but the protein
cannot be detected in mature hepatocytes of normal adult
liver [17]. In the present study, AFP was not expressed at Day
2 and Day 5 but expression was detected upon incubation
in hepatocyte specification media at Day 10 and sustained at
the same high level at Day 15 following incubation for 5 days
in hepatocyte maturation medium. Similarly, expression of
CK19, an intermediate filament protein possibly involved in
cellular restructuring in early liver maturation, was induced
at Day 10. Both AFP and CK19 have been shown to be
expressed in immature hepatocytes early in liver development
in humans but are differentially regulated when the fetal
immature hepatocyte compartment is remodeled to form
distinct populations of more mature hepatocytes and bile
duct cells. Thus, while expression of CK19 is sustained in the
newly formed bile duct cells, its expression is downregulated
in the maturing fetal hepatocytes [17, 18]. Interestingly, a
decreased intensity in expression of AFP and CK19 proteins
was found at Day 20 in the maturing hepatocyte-like cells.
In contrast, albumin (ALB), a major plasma carrier protein
exclusively produced by hepatocytes and a well-established
biomarker for functional hepatocytes, showed a gradual
increase in expression upon incubation in the hepatocyte
maturation medium. It is worth noting that addition of
oncostatin M to induce further maturation of hepatocyte-
like cells showed no effect on the parameters measured in
the current study (data not shown). Collectively, our data
is in concordance with Touboul et al. [14] showing that the
sequential addition of growth factors and small molecules to
a chemically defined medium can direct human embryonic
stem cells along the hepatic lineage and result in a hepatocyte-
like cell phenotype.
3.2. Alterations of Mitochondrial Morphology during Dif-
ferentiation along the Hepatocytic Lineage. Cytochrome 𝑐
oxidase (complex IV) is the fourth and final enzyme of
the ETC and is only located in the inner mitochondrial
membrane. As complex IV is the final electron acceptor of the
ETC, the enzyme is essential for oxidative phosphorylation.
Immunofluorescence staining of complex IV with an anti-
body against COX4 showed tight perinuclear clustering of the
complex and therebymitochondria in cells at Day 2 andDay 5
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(Figure 2(a)). Upon 5 days’ incubation in hepatic specification
media, cells at Day 10 showed expansion of mitochondria
in the cytoplasm with formation of thin mitochondrial
networks (Figures 2(a) and 2(b)). Similar observations were
made at Day 15 and Day 20 after incubation in hepatocyte
maturation media.
3.3. Glycolytic Profiles during Differentiation along the Hepa-
tocytic Lineage. Attributes of glycolysis were measured as a
result of lactate mediated acidification of media surrounding
the cells. Rates of glycolysis were determined as percent
increase of extracellular acidification rate after addition of
glucose. At Day 2 when the cells had a stem cell phenotype,
the glycolytic rate was 146%.This rate was increased at Day 5
upon incubation in endoderm differentiation media to 165%
and reached a maximum of 248% at Day 10 after incubation
in hepatic specification media which was significant higher
than rate of glycolysis measured at other time points (𝑃 <
0.001, 𝑛 = 8). Upon further differentiation along the hepatic
lineage by incubation in hepatocyte maturation media, the
glycolytic rate was reduced to 117% and 94% at Day 15 and
Day 20, respectively (Figures 3(a) and 3(b)). This signifies
an increasing requirement of ATP produced by glycolysis
through the first 10 days of differentiation, reaching an
absolutemaximumatDay 10 after incubation in hepatic spec-
ification media. Upon incubation in hepatocyte maturation
media, ATP produced by glycolysis decreases dramatically,
and it is at Day 20—our latest time point harvested—no
longer statistically discernable from cells that have not been
exposed to glucose (Figures 3(a) and 3(b)).
Glycolytic reserve capacity is a measure of the difference
in extracellular acidification rate in cells before and after
treatment with oligomycin. Oligomycin inhibits the ATP
synthase and thereby ATP produced by oxidative phos-
phorylation. Glycolytic reserve capacity therefore reflects
the compensatory increase of glycolysis corresponding to
the level of ATP no longer produced by oxidative phos-
phorylation. During the differentiation regimen, glycolytic
reserve capacity is not present in stem cells measured at
Day 2 and upon hepatic specification at Day 10 (Figures
3(a) and 3(c)). This indicates that, at these time points,
ATP demand is almost exclusively met by glycolysis. Upon
incubation in hepatocyte maturation media at Day 15 and
Day 20, the glycolytic reserve capacity is increased to 14%.
This increase suggests an emerging requirement of ATP
produced by oxidative phosphorylation at these later time
points. Interestingly, upon 3 days of incubation in endoderm
differentiation media, measured at Day 5, cells display the
highest glycolytic capacity at 22% above basal rate. This
capacity is significant compared to the glycolytic capacity of
cells harvested at Day 2 and Day 10 (𝑃 < 0.05, 𝑛 = 8)
suggesting that oxidative phosphorylation also is important
at Day 5 when cells have been induced to differentiate to
definitive endoderm in the endoderm differentiation media.
3.4. Oxidative Phosphorylation during Differentiation along
the Hepatic Lineage. Throughout the differentiation regimen,
cellular ATP turnover and reserve respiratory capacity were
determined as attributes of oxidative phosphorylation. Mea-
surements of ATP turnover rates revealed that, at all time
points investigated in the course of hepatic differentiation,
40–70% of oxygen was utilized by oxidative phosphorylation.
The maximal oxygen consumption rate was present at Day 5
upon differentiation in definitive endoderm inductionmedia
and was significantly higher than the following time points
(𝑃 < 0.001–0.05. 𝑛 = 8, Figures 4(a) and 4(b)). Lowest
consumption was measured at Day 20 when cells had been
cultured in hepatocyte maturationmedia for 10 days (Figures
4(a) and 4(b)). This demonstrates activity of the oxidative
phosphorylation throughout all stages of differentiation.
When looking at basal rate measured during the course of
hepatic lineage differentiation, lowest levels measured were
at Day 2 (Stem Cell) and highest ones were at Day 5 (Endo
Diff), Day 15 (Early Hep Mat), and Day 20 (Late Hep Mat)
(Figure 4(d)).The basal rates are presented as nonnormalized
levels; however the cell count of each processed stage was
115.000 ± 10.000 cells per well (Figure 2(c)).
Reserve respiratory capacity is a measure for the differ-
ence between ATP produced by oxidative phosphorylation at
basal and that atmaximal activity.Through the differentiation
regimen, no reserve respiratory capacity was detectable in
cells until Day 15when they had been incubated in hepatocyte
maturation media for 5 days. At this time point the reserve
capacity was at 138% of basal respiration and significantly
higher than the previous three time points investigated (𝑃 <
0.001, 𝑛 = 8) (Figures 4(a) and 4(c)). Prior to Day 15,
the reserve respiratory capacity was lower than the basal
respiration.This indicates the presence of very sensitivemito-
chondria, and we argue that the drop in respiratory capacity
is caused by mitochondrial stress induced by treatment with
oligomycin and the discrete mechanical force exerted by
the XF24 Extracellular Flux Analyzer during measurements
of bioenergetics. However, our data suggest that, in cells
harvested at Day 2, Day 5, and Day 10, reserve respiratory
capacity is completely absent. A significant increase of reserve
respiratory capacity is seen upon incubation in hepatocyte
maturation media at Day 15 and Day 20.
4. Discussion
Mitochondrial dysfunction affecting stem cells has, at least in
mice, been related to premature aging [1, 3]. This underlines
the importance of a detailed understanding of the role played
bymitochondria in stem cell differentiation. In this study, the
bioenergetics and mitochondrial network were evaluated at
specific time points in the course of stem cell differentiation
along the hepatic cell lineage using the human embryonic
stem cell line BG01V/hOG.
The adult mature hepatocyte is rich in mitochondria
and shows an extraordinary capacity to participate in liver
regeneration. The physiologic phenotype of an aging liver is
associated with a decreased ability of liver regeneration [19]
and a decline of both mitochondrial DNA copy-number and
level of oxidative phosphorylation [20]. A decrease of these
two mitochondrial properties has been shown to markedly
reduce the regenerative abilities of the liver, suggesting a
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Figure 3: Measurement of acidification rate at five successive time points in the course of BG01V/hOG (hESC) differentiation along the
hepatic lineage. (a) Parameters of glycolysis were determined according to rate of acidification after addition of glucose, oligomycin, and
2-DG. (b) Rate of glycolysis was measured as increase of acidification rate after addition of glucose. (c) Glycolytic capacity was measured after
addition of glucose and oligomycin (∗𝑃 < 0.05, ∗∗𝑃 < 0.01, and ∗∗∗𝑃 < 0.001; 𝑛 = 8; error bars indicate SD).
direct link between mitochondrial fitness of hepatocytes and
regenerative abilities of the liver [21].
From the rate of glycolysis determined in this study, it
is evident that glycolysis is predominant through the entire
course of hepatic lineage differentiation, reaching peak level
upon incubation in hepatic specification media in what can
be argued to be hepatic progenitor cells and lowest level upon
incubation in hepatocyte maturation media in what can be
reasoned to be hepatocyte-like cells. This is in accordance
with the literature stating that glycolysis is the sole provider
of ATP in stem cells [6, 22]. Nevertheless, throughout all
investigated time points in the course of differentiation, we
can demonstrate a presence of oxidative phosphorylation,
where an ATP turnover is evident. However, a reserve
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Figure 4: Measurement of oxygen consumption rate at five successive time points in the course of BG01V/hOG (hESC) differentiation along
the hepatic lineage. (a) Parameters of oxidative phosphorylation were determined according to rate of oxygen consumption after addition of
oligomycin, FCCP, and antimycin A. (b) ATP turnover was measured as percentagewise decrease of oxygen consumption after addition of
oligomycin. (c) Reserve respiratory capacity was measured as percentage of basal respiration, after addition of FCCP. (d) Basal respiration
measured in pMoles oxygen consumption per minute (∗𝑃 < 0.05, ∗∗𝑃 < 0.01, and ∗∗∗𝑃 < 0.001; 𝑛 = 8; error bars indicate SD).
respiratory capacity only becomes significant at Day 15 and
Day 20 upon incubation in hepatocyte maturation media.
When oxidative phosphorylation is inhibited by the ATP
synthase inhibitor oligomycin, a compensatory increase of
glycolysis may ensue.This increase is defined as the glycolytic
reserve capacity. Cells at Day 2 and Day 10 do not display
any glycolytic reserve capacity indicating that the oxidative
phosphorylation measured at these two time points is not
needed for ATP synthesis. Oxidative phosphorylation yields
other substrates than ATP. The flavoenzyme dihydroorotate
dehydrogenase is a rate-limiting enzyme involved in the
de novo synthesis of pyrimidines (reviewed in [23]). The
function of the enzyme is linked to the electron transport
chain, and the de novo synthesis of pyrimidines is therefore
reliant on an active oxidative phosphorylation. It is therefore
possible that one role of oxidative phosphorylation demon-
strated in stem cells (Day 2) and cells specified to hepatic
progenitors (Day 10) is to produce pyrimidines and derived
substrates rather than supplying ATP to the cell.
In this study the mitochondrial network was demon-
strated to expand once cells had been specified to hepatic
progenitors (Day 10) displaying maximum volume upon
maturation to hepatocyte-like cells (Day 15 and Day 20).
This expansion was accompanied with an increase of reserve
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respiratory capacity upon incubation in hepatocyte matu-
ration media at Day 15 and Day 20. These last two time
points in the differentiation regimen were also characterized
with markedly decreased levels of glycolysis and increased
levels of glycolytic reserve capacity. Together this highlights
the importance of oxidative phosphorylation at the period
of early hepatic maturation and emphasizes the transi-
tion from hepatic specification to hepatocyte maturation
as a period where differentiating cells are potentially more
prone to mitochondrial dysfunction than at other stages of
differentiation.
Interestingly, we show that cells upon induction in endo-
derm differentiation media and harvested at Day 5 have
an intermittent increase of glycolytic reserve capacity. This
is coupled with a basal rate comparable to that of cells
incubated in hepatocyte maturation media and harvested at
Day 15 and Day 20 and high levels of ATP turnover. As the
mitochondrial network at Day 5 still shows tight perinuclear
localization and as cells harvested at time points before (Day
2) and after (Day 10) do not display any glycolytic reserve
capacity it is tempting to speculate that such an intermittent
dependency on oxidative phosphorylation could be a safe-
guard to allow only differentiating stem cells with functional
mitochondria to progress along the course of differentiation.
A similar safeguard is hypothesized in fertilized oocytes
[24].
Mitochondrial dysfunction of stem cells severely impacts
self-renewal capacity and in turn has the potential to result
in a progeroid phenotype [3]. Inadequate oxidative phospho-
rylation has the potential to affect cells through decreased
production of ATP, by altering levels of mitochondrial pro-
duced ROS functioning as second-messenger molecules and
by depleting levels of NAD+ (reviewed in [23]). In turn
this has been hypothesized to result in stem cells showing
increased sensitivity to stress factors or stem cells that are
detained at a specific differentiation stage [22, 25]. Despite
all of the work conducted, the exact mechanism linking
mitochondrial dysfunction to progeroid stem cells has not yet
been described, which is most likely due to the very dynamic
nature of differentiating stem cells. In this study, we have
described the bioenergetics of a hESC line differentiating
along the hepatic lineage and we identified the transition
between hepatic specification and hepatocyte maturation
as a period, where mitochondrial function is especially
important. Our results will contribute to elucidating the
relationship between mitochondrial fitness, stem cell health,
and aging.
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